Does The Market Have A Low Tolerance For JEMTEC Inc.'s (CVE:JTC) Mixed Fundamentals?
With its stock down 5.5% over the past week, it is easy to disregard JEMTEC (CVE:JTC). It is possible that the ...
Vaxcyte Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding Study
At All Doses Evaluated, VAX-24 Was Well-Tolerated and Demonstrated a Safety and Tolerability Profile Similar to Prevnar 20® (PCV20) -- -- At ...